nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—NAT2—breast cancer	0.263	0.606	CbGaD
Sulfamethoxazole—PTGS1—breast cancer	0.0816	0.188	CbGaD
Sulfamethoxazole—CYP3A4—breast cancer	0.0476	0.11	CbGaD
Sulfamethoxazole—ALB—breast cancer	0.0416	0.0958	CbGaD
Sulfamethoxazole—UGT1A9—Irinotecan—breast cancer	0.0343	0.107	CbGbCtD
Sulfamethoxazole—CYP2C9—Anastrozole—breast cancer	0.0224	0.0695	CbGbCtD
Sulfamethoxazole—CYP2C8—Lapatinib—breast cancer	0.0214	0.0664	CbGbCtD
Sulfamethoxazole—CYP3A4—Exemestane—breast cancer	0.0172	0.0533	CbGbCtD
Sulfamethoxazole—CYP2C9—Idarubicin—breast cancer	0.0169	0.0526	CbGbCtD
Sulfamethoxazole—CYP2C8—Raloxifene—breast cancer	0.0162	0.0504	CbGbCtD
Sulfamethoxazole—CYP3A4—Letrozole—breast cancer	0.0146	0.0453	CbGbCtD
Sulfamethoxazole—CYP3A4—Anastrozole—breast cancer	0.013	0.0404	CbGbCtD
Sulfamethoxazole—CYP3A4—Toremifene—breast cancer	0.0119	0.0369	CbGbCtD
Sulfamethoxazole—CYP3A4—Fulvestrant—breast cancer	0.0111	0.0343	CbGbCtD
Sulfamethoxazole—CYP2C8—Tamoxifen—breast cancer	0.0107	0.0333	CbGbCtD
Sulfamethoxazole—ALB—Irinotecan—breast cancer	0.0106	0.0331	CbGbCtD
Sulfamethoxazole—ALB—Fluorouracil—breast cancer	0.0102	0.0317	CbGbCtD
Sulfamethoxazole—CYP3A4—Thiotepa—breast cancer	0.00985	0.0306	CbGbCtD
Sulfamethoxazole—CYP2C9—Capecitabine—breast cancer	0.00929	0.0288	CbGbCtD
Sulfamethoxazole—CYP3A4—Ixabepilone—breast cancer	0.00901	0.028	CbGbCtD
Sulfamethoxazole—CYP3A4—Lapatinib—breast cancer	0.00868	0.0269	CbGbCtD
Sulfamethoxazole—CYP2C8—Paclitaxel—breast cancer	0.00834	0.0259	CbGbCtD
Sulfamethoxazole—CYP2C8—Fluorouracil—breast cancer	0.00789	0.0245	CbGbCtD
Sulfamethoxazole—CYP2C9—Tamoxifen—breast cancer	0.00747	0.0232	CbGbCtD
Sulfamethoxazole—CYP3A4—Raloxifene—breast cancer	0.00657	0.0204	CbGbCtD
Sulfamethoxazole—CYP2C9—Paclitaxel—breast cancer	0.00582	0.0181	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—breast cancer	0.00563	0.0175	CbGbCtD
Sulfamethoxazole—CYP2C9—Fluorouracil—breast cancer	0.00551	0.0171	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinorelbine—breast cancer	0.00481	0.0149	CbGbCtD
Sulfamethoxazole—CYP3A4—Tamoxifen—breast cancer	0.00434	0.0135	CbGbCtD
Sulfamethoxazole—CYP3A4—Mitoxantrone—breast cancer	0.00424	0.0132	CbGbCtD
Sulfamethoxazole—CYP3A4—Paclitaxel—breast cancer	0.00338	0.0105	CbGbCtD
Sulfamethoxazole—CYP3A4—Irinotecan—breast cancer	0.00334	0.0104	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinblastine—breast cancer	0.00297	0.00921	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—breast cancer	0.00244	0.00759	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—breast cancer	0.00182	0.00566	CbGbCtD
Sulfamethoxazole—NAT1—endometrium—breast cancer	0.00181	0.0779	CbGeAlD
Sulfamethoxazole—NAT1—pituitary gland—breast cancer	0.00164	0.0705	CbGeAlD
Sulfamethoxazole—NAT1—adipose tissue—breast cancer	0.00163	0.0702	CbGeAlD
Sulfamethoxazole—NAT1—female reproductive system—breast cancer	0.0015	0.0645	CbGeAlD
Sulfamethoxazole—NAT1—adrenal gland—breast cancer	0.00146	0.063	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—breast cancer	0.00141	0.0609	CbGeAlD
Sulfamethoxazole—NAT2—endocrine gland—breast cancer	0.00139	0.06	CbGeAlD
Sulfamethoxazole—NAT1—female gonad—breast cancer	0.00136	0.0587	CbGeAlD
Sulfamethoxazole—NAT1—endocrine gland—breast cancer	0.00127	0.0546	CbGeAlD
Sulfamethoxazole—ALB—mammary gland—breast cancer	0.000992	0.0427	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—breast cancer	0.000876	0.0377	CbGeAlD
Sulfamethoxazole—UGT1A9—endocrine gland—breast cancer	0.000753	0.0324	CbGeAlD
Sulfamethoxazole—CYP2C8—mammary gland—breast cancer	0.000697	0.03	CbGeAlD
Sulfamethoxazole—CYP2C9—mammary gland—breast cancer	0.000619	0.0267	CbGeAlD
Sulfamethoxazole—PTGS1—nipple—breast cancer	0.000468	0.0201	CbGeAlD
Sulfamethoxazole—ALB—adrenal gland—breast cancer	0.0004	0.0172	CbGeAlD
Sulfamethoxazole—Sulfathiazole—CYP19A1—breast cancer	0.000361	0.197	CrCbGaD
Sulfamethoxazole—CYP2C8—endometrium—breast cancer	0.000348	0.015	CbGeAlD
Sulfamethoxazole—CYP2C8—pituitary gland—breast cancer	0.000315	0.0136	CbGeAlD
Sulfamethoxazole—PTGS1—epithelium—breast cancer	0.000315	0.0136	CbGeAlD
Sulfamethoxazole—Dapsone—NAT2—breast cancer	0.000312	0.17	CrCbGaD
Sulfamethoxazole—PTGS1—skin of body—breast cancer	0.000299	0.0129	CbGeAlD
Sulfamethoxazole—CYP2C8—female reproductive system—breast cancer	0.000288	0.0124	CbGeAlD
Sulfamethoxazole—PTGS1—endometrium—breast cancer	0.000282	0.0122	CbGeAlD
Sulfamethoxazole—PTGS1—uterus—breast cancer	0.00026	0.0112	CbGeAlD
Sulfamethoxazole—CYP2C9—female reproductive system—breast cancer	0.000256	0.011	CbGeAlD
Sulfamethoxazole—PTGS1—pituitary gland—breast cancer	0.000255	0.011	CbGeAlD
Sulfamethoxazole—PTGS1—adipose tissue—breast cancer	0.000254	0.011	CbGeAlD
Sulfamethoxazole—CYP2C8—endocrine gland—breast cancer	0.000244	0.0105	CbGeAlD
Sulfamethoxazole—ALB—lymph node—breast cancer	0.00024	0.0103	CbGeAlD
Sulfamethoxazole—PTGS1—female reproductive system—breast cancer	0.000234	0.0101	CbGeAlD
Sulfamethoxazole—PTGS1—adrenal gland—breast cancer	0.000228	0.00983	CbGeAlD
Sulfamethoxazole—Sulfanilamide—CA9—breast cancer	0.00022	0.12	CrCbGaD
Sulfamethoxazole—CYP2C9—endocrine gland—breast cancer	0.000217	0.00933	CbGeAlD
Sulfamethoxazole—PTGS1—female gonad—breast cancer	0.000213	0.00916	CbGeAlD
Sulfamethoxazole—PTGS1—endocrine gland—breast cancer	0.000198	0.00852	CbGeAlD
Sulfamethoxazole—CYP3A4—female reproductive system—breast cancer	0.000195	0.00841	CbGeAlD
Sulfamethoxazole—CYP3A4—endocrine gland—breast cancer	0.000165	0.00712	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—breast cancer	0.000148	0.0806	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—breast cancer	0.000145	0.0788	CrCbGaD
Sulfamethoxazole—PTGS1—lymph node—breast cancer	0.000137	0.00589	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—breast cancer	0.000112	0.0611	CrCbGaD
Sulfamethoxazole—Sulfaphenazole—CYP2D6—breast cancer	9.94e-05	0.0541	CrCbGaD
Sulfamethoxazole—Dapsone—PTGS1—breast cancer	9.68e-05	0.0527	CrCbGaD
Sulfamethoxazole—Sulfadiazine—CYP3A4—breast cancer	9.32e-05	0.0508	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2D6—breast cancer	7.38e-05	0.0402	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP3A4—breast cancer	6.33e-05	0.0345	CrCbGaD
Sulfamethoxazole—Dapsone—CYP3A4—breast cancer	5.65e-05	0.0308	CrCbGaD
Sulfamethoxazole—Dapsone—PTGS2—breast cancer	5.53e-05	0.0301	CrCbGaD
Sulfamethoxazole—Hypersensitivity—Fluorouracil—breast cancer	4.56e-05	0.000358	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Paclitaxel—breast cancer	4.55e-05	0.000358	CcSEcCtD
Sulfamethoxazole—Fatigue—Paclitaxel—breast cancer	4.54e-05	0.000357	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—breast cancer	4.53e-05	0.000356	CcSEcCtD
Sulfamethoxazole—Asthenia—Gemcitabine—breast cancer	4.52e-05	0.000355	CcSEcCtD
Sulfamethoxazole—Arthralgia—Capecitabine—breast cancer	4.51e-05	0.000355	CcSEcCtD
Sulfamethoxazole—Myalgia—Capecitabine—breast cancer	4.51e-05	0.000355	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.48e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—breast cancer	4.48e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—breast cancer	4.48e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—breast cancer	4.47e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—breast cancer	4.47e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Pruritus—Gemcitabine—breast cancer	4.45e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Nausea—Thiotepa—breast cancer	4.45e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—breast cancer	4.44e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Irinotecan—breast cancer	4.42e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mitoxantrone—breast cancer	4.42e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—breast cancer	4.41e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—breast cancer	4.4e-05	0.000346	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—breast cancer	4.38e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Pruritus—Fluorouracil—breast cancer	4.38e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—breast cancer	4.37e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—breast cancer	4.37e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—breast cancer	4.37e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—breast cancer	4.34e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—breast cancer	4.33e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Paclitaxel—breast cancer	4.31e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gemcitabine—breast cancer	4.31e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—breast cancer	4.3e-05	0.000338	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—breast cancer	4.29e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—breast cancer	4.29e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Dizziness—Irinotecan—breast cancer	4.27e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—breast cancer	4.26e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—breast cancer	4.26e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Capecitabine—breast cancer	4.24e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—breast cancer	4.24e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—breast cancer	4.24e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fluorouracil—breast cancer	4.24e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Capecitabine—breast cancer	4.24e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—breast cancer	4.23e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Skin disorder—Capecitabine—breast cancer	4.2e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—breast cancer	4.19e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Urticaria—Paclitaxel—breast cancer	4.19e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—breast cancer	4.17e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Paclitaxel—breast cancer	4.17e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Paclitaxel—breast cancer	4.17e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—breast cancer	4.16e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—breast cancer	4.13e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Anorexia—Capecitabine—breast cancer	4.12e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Vomiting—Mitoxantrone—breast cancer	4.11e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Vomiting—Irinotecan—breast cancer	4.11e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—breast cancer	4.09e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Dizziness—Fluorouracil—breast cancer	4.09e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—breast cancer	4.08e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—breast cancer	4.08e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Rash—Mitoxantrone—breast cancer	4.08e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Rash—Irinotecan—breast cancer	4.08e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Dermatitis—Irinotecan—breast cancer	4.07e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Dermatitis—Mitoxantrone—breast cancer	4.07e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—breast cancer	4.07e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—breast cancer	4.07e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Headache—Irinotecan—breast cancer	4.05e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Headache—Mitoxantrone—breast cancer	4.05e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—breast cancer	4.04e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—breast cancer	4.01e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Vomiting—Gemcitabine—breast cancer	4e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—breast cancer	3.98e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—breast cancer	3.97e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Rash—Gemcitabine—breast cancer	3.97e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gemcitabine—breast cancer	3.97e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—breast cancer	3.96e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—breast cancer	3.95e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—breast cancer	3.95e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Headache—Gemcitabine—breast cancer	3.94e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Capecitabine—breast cancer	3.94e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Vomiting—Fluorouracil—breast cancer	3.94e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—breast cancer	3.93e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—breast cancer	3.92e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Insomnia—Capecitabine—breast cancer	3.91e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Rash—Fluorouracil—breast cancer	3.9e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fluorouracil—breast cancer	3.9e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—breast cancer	3.88e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Paclitaxel—breast cancer	3.88e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Headache—Fluorouracil—breast cancer	3.88e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—breast cancer	3.88e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—breast cancer	3.86e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—breast cancer	3.86e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Capecitabine—breast cancer	3.86e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—breast cancer	3.85e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—breast cancer	3.85e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Nausea—Irinotecan—breast cancer	3.84e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Nausea—Mitoxantrone—breast cancer	3.84e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—breast cancer	3.83e-05	0.000301	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—breast cancer	3.82e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Capecitabine—breast cancer	3.81e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—breast cancer	3.81e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Asthenia—Paclitaxel—breast cancer	3.78e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Capecitabine—breast cancer	3.76e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Nausea—Gemcitabine—breast cancer	3.74e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Capecitabine—breast cancer	3.73e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Fatigue—Capecitabine—breast cancer	3.73e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Pruritus—Paclitaxel—breast cancer	3.73e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—breast cancer	3.72e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—breast cancer	3.71e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—breast cancer	3.69e-05	0.00029	CcSEcCtD
Sulfamethoxazole—Nausea—Fluorouracil—breast cancer	3.68e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—breast cancer	3.67e-05	0.000288	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—breast cancer	3.66e-05	0.000288	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—breast cancer	3.65e-05	0.000287	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—breast cancer	3.62e-05	0.000285	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Paclitaxel—breast cancer	3.61e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—breast cancer	3.59e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—breast cancer	3.54e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—breast cancer	3.54e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Capecitabine—breast cancer	3.54e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—breast cancer	3.54e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—breast cancer	3.53e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—breast cancer	3.53e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—breast cancer	3.53e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—breast cancer	3.52e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Dizziness—Paclitaxel—breast cancer	3.49e-05	0.000274	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—breast cancer	3.44e-05	0.000271	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—breast cancer	3.44e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Urticaria—Capecitabine—breast cancer	3.44e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Capecitabine—breast cancer	3.42e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Capecitabine—breast cancer	3.42e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—breast cancer	3.42e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—breast cancer	3.42e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—breast cancer	3.36e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—breast cancer	3.36e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—breast cancer	3.35e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Vomiting—Paclitaxel—breast cancer	3.35e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.34e-05	0.000262	CcSEcCtD
Sulfamethoxazole—Rash—Paclitaxel—breast cancer	3.32e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Dermatitis—Paclitaxel—breast cancer	3.32e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—breast cancer	3.32e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—breast cancer	3.32e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—breast cancer	3.31e-05	0.00026	CcSEcCtD
Sulfamethoxazole—Headache—Paclitaxel—breast cancer	3.3e-05	0.00026	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—breast cancer	3.29e-05	0.000259	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—breast cancer	3.22e-05	0.000253	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—breast cancer	3.22e-05	0.000253	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—breast cancer	3.21e-05	0.000252	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—breast cancer	3.2e-05	0.000251	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Capecitabine—breast cancer	3.19e-05	0.000251	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—breast cancer	3.16e-05	0.000248	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—breast cancer	3.16e-05	0.000248	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—breast cancer	3.15e-05	0.000248	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—breast cancer	3.14e-05	0.000247	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—breast cancer	3.14e-05	0.000247	CcSEcCtD
Sulfamethoxazole—Nausea—Paclitaxel—breast cancer	3.13e-05	0.000246	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—breast cancer	3.13e-05	0.000246	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.12e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Asthenia—Capecitabine—breast cancer	3.1e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—breast cancer	3.07e-05	0.000241	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—breast cancer	3.07e-05	0.000241	CcSEcCtD
Sulfamethoxazole—Pruritus—Capecitabine—breast cancer	3.06e-05	0.000241	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—breast cancer	3.06e-05	0.00024	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—breast cancer	3.06e-05	0.00024	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—breast cancer	3.01e-05	0.000237	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—breast cancer	2.98e-05	0.000234	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—breast cancer	2.96e-05	0.000233	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Capecitabine—breast cancer	2.96e-05	0.000233	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—breast cancer	2.96e-05	0.000232	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—breast cancer	2.95e-05	0.000232	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—breast cancer	2.95e-05	0.000232	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—breast cancer	2.93e-05	0.000231	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—breast cancer	2.93e-05	0.00023	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—breast cancer	2.91e-05	0.000229	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—breast cancer	2.91e-05	0.000229	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—breast cancer	2.91e-05	0.000229	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.89e-05	0.000227	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—breast cancer	2.87e-05	0.000226	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—breast cancer	2.87e-05	0.000226	CcSEcCtD
Sulfamethoxazole—Dizziness—Capecitabine—breast cancer	2.86e-05	0.000225	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—breast cancer	2.84e-05	0.000223	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—breast cancer	2.83e-05	0.000223	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—breast cancer	2.82e-05	0.000221	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—breast cancer	2.81e-05	0.000221	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—breast cancer	2.8e-05	0.00022	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—breast cancer	2.8e-05	0.00022	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—breast cancer	2.79e-05	0.000219	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—breast cancer	2.78e-05	0.000219	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—breast cancer	2.78e-05	0.000218	CcSEcCtD
Sulfamethoxazole—Vomiting—Capecitabine—breast cancer	2.75e-05	0.000216	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—breast cancer	2.75e-05	0.000216	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—breast cancer	2.73e-05	0.000215	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—breast cancer	2.73e-05	0.000215	CcSEcCtD
Sulfamethoxazole—Rash—Capecitabine—breast cancer	2.73e-05	0.000214	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—breast cancer	2.73e-05	0.000214	CcSEcCtD
Sulfamethoxazole—Dermatitis—Capecitabine—breast cancer	2.72e-05	0.000214	CcSEcCtD
Sulfamethoxazole—Headache—Capecitabine—breast cancer	2.71e-05	0.000213	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—breast cancer	2.71e-05	0.000213	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—breast cancer	2.69e-05	0.000211	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—breast cancer	2.66e-05	0.000209	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—breast cancer	2.65e-05	0.000209	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—breast cancer	2.65e-05	0.000209	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—breast cancer	2.63e-05	0.000207	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—breast cancer	2.62e-05	0.000206	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—breast cancer	2.6e-05	0.000205	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—breast cancer	2.6e-05	0.000204	CcSEcCtD
Sulfamethoxazole—Nausea—Capecitabine—breast cancer	2.57e-05	0.000202	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—breast cancer	2.56e-05	0.000201	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—breast cancer	2.55e-05	0.0002	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—breast cancer	2.55e-05	0.0002	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.54e-05	0.0002	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—breast cancer	2.52e-05	0.000198	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—breast cancer	2.49e-05	0.000195	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—breast cancer	2.46e-05	0.000194	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—breast cancer	2.45e-05	0.000193	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—breast cancer	2.42e-05	0.000191	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—breast cancer	2.41e-05	0.000189	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—breast cancer	2.4e-05	0.000189	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—breast cancer	2.39e-05	0.000188	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—breast cancer	2.38e-05	0.000187	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—breast cancer	2.38e-05	0.000187	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—breast cancer	2.37e-05	0.000186	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—breast cancer	2.31e-05	0.000182	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—breast cancer	2.28e-05	0.000179	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—breast cancer	2.28e-05	0.000179	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—breast cancer	2.22e-05	0.000175	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—breast cancer	2.22e-05	0.000174	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—breast cancer	2.2e-05	0.000173	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—breast cancer	2.2e-05	0.000173	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—breast cancer	2.2e-05	0.000173	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—breast cancer	2.16e-05	0.00017	CcSEcCtD
Sulfamethoxazole—Pruritus—Epirubicin—breast cancer	2.13e-05	0.000168	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—breast cancer	2.13e-05	0.000167	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—breast cancer	2.06e-05	0.000162	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—breast cancer	2.05e-05	0.000161	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—breast cancer	2.05e-05	0.000161	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—breast cancer	2.03e-05	0.00016	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—breast cancer	2.03e-05	0.000159	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—breast cancer	2.02e-05	0.000159	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—breast cancer	2e-05	0.000157	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—breast cancer	1.99e-05	0.000157	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—breast cancer	1.97e-05	0.000155	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—breast cancer	1.92e-05	0.000151	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—breast cancer	1.91e-05	0.00015	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—breast cancer	1.91e-05	0.00015	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—breast cancer	1.9e-05	0.000149	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—breast cancer	1.9e-05	0.000149	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—breast cancer	1.89e-05	0.000148	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—breast cancer	1.84e-05	0.000145	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—breast cancer	1.79e-05	0.000141	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—breast cancer	1.77e-05	0.000139	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—breast cancer	1.76e-05	0.000138	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—breast cancer	1.76e-05	0.000138	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—breast cancer	1.75e-05	0.000137	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—breast cancer	1.66e-05	0.00013	CcSEcCtD
Sulfamethoxazole—ALB—Metabolism—PTGS1—breast cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ENO1—breast cancer	3.76e-06	4.09e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.74e-06	4.07e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ERCC2—breast cancer	3.74e-06	4.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.72e-06	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MED12—breast cancer	3.71e-06	4.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—DPYD—breast cancer	3.71e-06	4.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2D6—breast cancer	3.7e-06	4.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2D6—breast cancer	3.68e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.68e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.68e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAF1—breast cancer	3.67e-06	4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDOA—breast cancer	3.65e-06	3.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOA2—breast cancer	3.64e-06	3.96e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—breast cancer	3.62e-06	3.94e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOA2—breast cancer	3.62e-06	3.94e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—breast cancer	3.58e-06	3.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA3—breast cancer	3.55e-06	3.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADSL—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PHGDH—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NME1—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FHL2—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UMPS—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FASN—breast cancer	3.53e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A2—breast cancer	3.52e-06	3.83e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—breast cancer	3.51e-06	3.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCHE—breast cancer	3.51e-06	3.82e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FASN—breast cancer	3.51e-06	3.82e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCHE—breast cancer	3.49e-06	3.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.48e-06	3.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—breast cancer	3.47e-06	3.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BRIP1—breast cancer	3.46e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LDHB—breast cancer	3.46e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HPSE—breast cancer	3.46e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	3.46e-06	3.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTR—breast cancer	3.45e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCG2—breast cancer	3.45e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CPT1A—breast cancer	3.45e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—breast cancer	3.45e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HPGDS—breast cancer	3.38e-06	3.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HBA1—breast cancer	3.36e-06	3.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NQO1—breast cancer	3.35e-06	3.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A1—breast cancer	3.35e-06	3.65e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A1—breast cancer	3.33e-06	3.63e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NQO1—breast cancer	3.33e-06	3.63e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—breast cancer	3.29e-06	3.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCC1—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA3—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMMR—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ACHE—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.28e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP3A4—breast cancer	3.27e-06	3.56e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.26e-06	3.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.25e-06	3.54e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP3A4—breast cancer	3.25e-06	3.54e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—breast cancer	3.24e-06	3.53e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.23e-06	3.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1B1—breast cancer	3.21e-06	3.5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1B1—breast cancer	3.19e-06	3.48e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—breast cancer	3.18e-06	3.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.18e-06	3.46e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	3.18e-06	3.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HSP90AA1—breast cancer	3.15e-06	3.43e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—breast cancer	3.14e-06	3.42e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HSP90AA1—breast cancer	3.13e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP17A1—breast cancer	3.11e-06	3.38e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.1e-06	3.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ENO1—breast cancer	3.07e-06	3.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS1—breast cancer	3.07e-06	3.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOA1—breast cancer	3.06e-06	3.34e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.06e-06	3.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOA1—breast cancer	3.05e-06	3.32e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.02e-06	3.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—STK11—breast cancer	3.02e-06	3.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP19A1—breast cancer	3.02e-06	3.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2D6—breast cancer	3.01e-06	3.28e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—breast cancer	3.01e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—STK11—breast cancer	3e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP19A1—breast cancer	3e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA4—breast cancer	3e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA9—breast cancer	3e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA2—breast cancer	2.96e-06	3.22e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—breast cancer	2.95e-06	3.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX2—breast cancer	2.93e-06	3.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA2—breast cancer	2.93e-06	3.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX4—breast cancer	2.89e-06	3.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SULT1A1—breast cancer	2.89e-06	3.15e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—breast cancer	2.87e-06	3.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FASN—breast cancer	2.87e-06	3.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCHE—breast cancer	2.86e-06	3.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.83e-06	3.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—breast cancer	2.82e-06	3.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—IDH1—breast cancer	2.82e-06	3.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA1—breast cancer	2.82e-06	3.07e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.82e-06	3.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—COMT—breast cancer	2.81e-06	3.06e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—breast cancer	2.8e-06	3.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—breast cancer	2.79e-06	3.04e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—COMT—breast cancer	2.79e-06	3.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAT2—breast cancer	2.79e-06	3.04e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—breast cancer	2.78e-06	3.02e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—breast cancer	2.77e-06	3.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—breast cancer	2.76e-06	3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ITPR1—breast cancer	2.75e-06	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—breast cancer	2.75e-06	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—breast cancer	2.74e-06	2.98e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ITPR1—breast cancer	2.73e-06	2.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A1—breast cancer	2.73e-06	2.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NQO1—breast cancer	2.73e-06	2.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.67e-06	2.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP3A4—breast cancer	2.66e-06	2.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.65e-06	2.88e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—breast cancer	2.65e-06	2.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—breast cancer	2.65e-06	2.88e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—breast cancer	2.63e-06	2.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1B1—breast cancer	2.61e-06	2.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—breast cancer	2.6e-06	2.83e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—breast cancer	2.59e-06	2.83e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—breast cancer	2.58e-06	2.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.57e-06	2.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOR1—breast cancer	2.57e-06	2.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—breast cancer	2.57e-06	2.8e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—breast cancer	2.57e-06	2.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.56e-06	2.79e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—breast cancer	2.56e-06	2.79e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—breast cancer	2.55e-06	2.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLA2G4A—breast cancer	2.55e-06	2.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOR1—breast cancer	2.55e-06	2.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA1—breast cancer	2.49e-06	2.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—breast cancer	2.46e-06	2.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—STK11—breast cancer	2.46e-06	2.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP19A1—breast cancer	2.46e-06	2.68e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—breast cancer	2.45e-06	2.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MED12—breast cancer	2.45e-06	2.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DPYD—breast cancer	2.45e-06	2.66e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—breast cancer	2.45e-06	2.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—breast cancer	2.43e-06	2.65e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—breast cancer	2.42e-06	2.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ERCC2—breast cancer	2.41e-06	2.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDOA—breast cancer	2.41e-06	2.62e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ERCC2—breast cancer	2.4e-06	2.61e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—breast cancer	2.4e-06	2.61e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—breast cancer	2.38e-06	2.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA3—breast cancer	2.34e-06	2.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A2—breast cancer	2.32e-06	2.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.31e-06	2.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—COMT—breast cancer	2.28e-06	2.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CPT1A—breast cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG2—breast cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTR—breast cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—breast cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—breast cancer	2.27e-06	2.47e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—breast cancer	2.26e-06	2.46e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—breast cancer	2.26e-06	2.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—breast cancer	2.24e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—breast cancer	2.24e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ITPR1—breast cancer	2.24e-06	2.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HPGDS—breast cancer	2.23e-06	2.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HBA1—breast cancer	2.22e-06	2.41e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—breast cancer	2.18e-06	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—breast cancer	2.16e-06	2.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACHE—breast cancer	2.16e-06	2.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—breast cancer	2.15e-06	2.34e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—breast cancer	2.11e-06	2.3e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—breast cancer	2.11e-06	2.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—breast cancer	2.09e-06	2.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOR1—breast cancer	2.09e-06	2.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—breast cancer	2.09e-06	2.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.09e-06	2.28e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—breast cancer	2.08e-06	2.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP17A1—breast cancer	2.05e-06	2.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ENO1—breast cancer	2.03e-06	2.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS1—breast cancer	2.03e-06	2.21e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—breast cancer	2.02e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—breast cancer	2e-06	2.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2e-06	2.18e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.99e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2D6—breast cancer	1.99e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—breast cancer	1.98e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ERCC2—breast cancer	1.96e-06	2.14e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—breast cancer	1.95e-06	2.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA2—breast cancer	1.95e-06	2.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—breast cancer	1.91e-06	2.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—breast cancer	1.9e-06	2.06e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FASN—breast cancer	1.89e-06	2.06e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCHE—breast cancer	1.88e-06	2.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—breast cancer	1.86e-06	2.03e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—breast cancer	1.85e-06	2.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NQO1—breast cancer	1.8e-06	1.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A1—breast cancer	1.8e-06	1.96e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—breast cancer	1.78e-06	1.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1B1—breast cancer	1.72e-06	1.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—breast cancer	1.7e-06	1.85e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—breast cancer	1.69e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.69e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—breast cancer	1.68e-06	1.82e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—breast cancer	1.67e-06	1.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—breast cancer	1.65e-06	1.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA1—breast cancer	1.64e-06	1.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.63e-06	1.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STK11—breast cancer	1.62e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP19A1—breast cancer	1.62e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—breast cancer	1.58e-06	1.72e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—breast cancer	1.57e-06	1.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—breast cancer	1.55e-06	1.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COMT—breast cancer	1.51e-06	1.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—breast cancer	1.5e-06	1.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—breast cancer	1.48e-06	1.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ITPR1—breast cancer	1.48e-06	1.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—breast cancer	1.46e-06	1.59e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—breast cancer	1.45e-06	1.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—breast cancer	1.45e-06	1.58e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—breast cancer	1.44e-06	1.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—breast cancer	1.42e-06	1.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—breast cancer	1.39e-06	1.52e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOR1—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—breast cancer	1.36e-06	1.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—breast cancer	1.35e-06	1.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—breast cancer	1.32e-06	1.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.31e-06	1.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ERCC2—breast cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—breast cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—breast cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—breast cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—breast cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—breast cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—breast cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—breast cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—breast cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—breast cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—breast cancer	9e-07	9.8e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—breast cancer	8.91e-07	9.7e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—breast cancer	8.88e-07	9.67e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—breast cancer	8.86e-07	9.64e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—breast cancer	8.5e-07	9.25e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—breast cancer	7.84e-07	8.54e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—breast cancer	7.77e-07	8.46e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—breast cancer	7.28e-07	7.92e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—breast cancer	7.25e-07	7.89e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—breast cancer	7.23e-07	7.88e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—breast cancer	6.78e-07	7.38e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—breast cancer	5.92e-07	6.45e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—breast cancer	4.78e-07	5.2e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—breast cancer	3.91e-07	4.25e-06	CbGpPWpGaD
